# Hospira, Inc. - Inspection Records Source: https://www.keypedia.com/companies/hospira-inc/d4decc1e-4b42-43bb-be2c-abcefbc7b965 > Inspection records and compliance data for Hospira, Inc. in Rocky Mount, North Carolina. Access full analysis and detailed observations. --- ## Details - Name: Hospira, Inc. - FEI Number: 1021343 - City: Rocky Mount - State: North Carolina - Country Name: United States - Address Line 1: 4285 N Wesleyan Blvd - Zip Code: 27804 - Facility Type: Pharmaceutical and Device Manufacturer / Gamma Irradiator - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE ## Related Documents - [FDA Inspection 1251941 - Hospira, Inc. - 2025-02-07](https://www.keypedia.com/records/fda_inspections/hospira-inc/c3272df1-cc67-40bd-9413-585626aec79f) — source: FDA, date: February 7, 2025 - [FDA Inspection 1251941 - Hospira, Inc. - 2025-02-07](https://www.keypedia.com/records/fda_inspections/hospira-inc/456d0466-e015-4a15-9cb9-540c0e8160e8) — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2025 - [483 - Hospira, Inc. - 2023-11-14](https://www.keypedia.com/records/483/hospira-inc/5c3e063a-836d-4935-b609-0dea69d3e704) — source: FDA, date: November 14, 2023 - [483 - Hospira, Inc. - 2019-11-21](https://www.keypedia.com/records/483/hospira-inc/e86d25f7-dbfb-46b3-a9cc-424f1d165750) — source: FDA, date: November 21, 2019 - [FDA Inspection 1110899 - Hospira, Inc. - 2019-11-21](https://www.keypedia.com/records/fda_inspections/hospira-inc/8bc1ca51-7f35-4184-ac20-80876c3d27fd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 21, 2019 - [483 - Hospira, Inc. - 2018-02-02](https://www.keypedia.com/records/483/hospira-inc/fe237d3b-7ac6-4cc0-a546-a4c2899ac024) — source: FDA, date: February 2, 2018 - [FDA Inspection 1039547 - Hospira, Inc. - 2018-02-02](https://www.keypedia.com/records/fda_inspections/hospira-inc/cda69c71-b01f-446f-b536-c0289c163dae) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 2, 2018 - [FDA Inspection 1039547 - Hospira, Inc. - 2018-02-02](https://www.keypedia.com/records/fda_inspections/hospira-inc/ff0a477b-a209-46bc-a7b5-cd6391330701) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 2, 2018 - [FDA Inspection 984874 - Hospira, Inc. - 2016-05-26](https://www.keypedia.com/records/fda_inspections/hospira-inc/52706499-eb6f-4bae-81f4-6170eee229e5) — classification: No Action Indicated (NAI), source: FDA, date: May 26, 2016 - [FDA Inspection 942202 - Hospira, Inc. - 2015-09-24](https://www.keypedia.com/records/fda_inspections/hospira-inc/5ffad654-432c-4279-bb5b-e6ff8854b145) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2015 - [FDA Inspection 942202 - Hospira, Inc. - 2015-09-24](https://www.keypedia.com/records/fda_inspections/hospira-inc/0849bdfa-4145-44ea-8de2-d3163ccef069) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2015 - [FDA Inspection 942202 - Hospira, Inc. - 2015-09-24](https://www.keypedia.com/records/fda_inspections/hospira-inc/46769e67-394a-4297-af1b-96bf2dd76ea8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2015 - [FDA Inspection 882908 - Hospira, Inc. - 2014-06-13](https://www.keypedia.com/records/fda_inspections/hospira-inc/b6bf0fae-9fb2-4e40-adf8-e6e1df7b789e) — classification: No Action Indicated (NAI), source: FDA, date: June 13, 2014 - [WARNING_LETTER - Hospira, Inc. - 2013-11-15](https://www.keypedia.com/records/warning_letter/hospira-inc/e87a2420-2ae9-450b-ba61-65d3dbff6f23) — source: FDA, date: November 15, 2013 - [483 - Hospira, Inc. - 2013-03-01](https://www.keypedia.com/records/483/hospira-inc/b0545b4f-6e65-4d0b-8823-a90867a7bedf) — source: FDA, date: March 1, 2013 - [483 - Hospira, Inc. - 2012-10-24](https://www.keypedia.com/records/483/hospira-inc/99e29fe1-698d-4c85-a456-eaabb6e76e7a) — source: FDA, date: October 24, 2012 - [483 - Hospira, Inc. - 2012-07-26](https://www.keypedia.com/records/483/hospira-inc/ecb9d0a0-1284-4b8c-89ac-f3ce4b72c2cb) — source: FDA, date: July 26, 2012 - [483 - Hospira, Inc. - 2011-08-04](https://www.keypedia.com/records/483/hospira-inc/985730f5-cef4-479b-8ac8-0e7241142062) — source: FDA, date: August 4, 2011 - [483 - Hospira, Inc. - 2011-08-04](https://www.keypedia.com/records/483/hospira-inc/e0d8b125-2d3c-41d0-bd52-31ea75e878f3) — source: FDA, date: August 4, 2011 - [483 - Hospira, Inc. - 2011-06-17](https://www.keypedia.com/records/483/hospira-inc/82896c82-4b42-450b-bb14-c9eb1b79cac1) — source: FDA, date: June 17, 2011 ## Related Companies - [The Procter & Gamble Manufacturing Company](https://www.keypedia.com/companies/the-procter-gamble-manufacturing-company/ceebac3f-c234-4225-b666-964153cdba97) - [Chartwell Pharmaceuticals LLC](https://www.keypedia.com/companies/chartwell-pharmaceuticals-llc/4a8c4844-be98-403a-8cb5-5fc90d592679) - [Chartwell Pharmaceuticals Carmel LLC](https://www.keypedia.com/companies/chartwell-pharmaceuticals-carmel-llc/7d10681a-1557-4f23-bde4-a9fad718e27f) - [Appco Pharma LLC](https://www.keypedia.com/companies/appco-pharma-llc/b4a77ba5-0e8a-47ae-94c2-951f5a0b2100) - [Sovereign Pharmaceuticals, LLC](https://www.keypedia.com/companies/sovereign-pharmaceuticals-llc/b8432227-cad1-4c55-91cc-a8c613f765fd) - [Frontage Laboratories, Inc.](https://www.keypedia.com/companies/frontage-laboratories-inc/1705f97d-14a3-4e46-b8a5-220bf2c4799f) - [Hospira Australia Pty Ltd.](https://www.keypedia.com/companies/hospira-australia-pty-ltd/43f04346-c63c-4c33-92ed-a42abafdd533) - [Cronus Pharma Specialities India Pvt Ltd](https://www.keypedia.com/companies/cronus-pharma-specialities-india-pvt-ltd/5eba515d-716e-4acb-b927-57e4973bb0c4) - [BOEHRINGER INGELHEIM PROMECO S.A. de C.V.](https://www.keypedia.com/companies/boehringer-ingelheim-promeco-sa-de-cv/d1f077c2-d2d3-4a71-b897-7595adbb343b) - [Carnegie Pharmaceutical Llc](https://www.keypedia.com/companies/carnegie-pharmaceutical-llc/871b6bed-cfd1-4953-90e7-bfd439dc2050) ## Related Officers - [Vascular Neurologist/Neurohospitalist/Medical Officer](https://www.keypedia.com/people/claudette-d-brooks/10f30b8f-2d20-4f92-84c1-862b31b81ce1) - [District Team Leader / District Team Leader Trainer](https://www.keypedia.com/people/jason-f-chancey/d4176303-5063-4cdd-87ba-32763b0cf6d0) - [Site Quality Director](https://www.keypedia.com/people/hector-e-jimenez/c1f2226a-36a2-428f-91e8-49758cf27467) - [Program Expert](https://www.keypedia.com/people/thomas-r-berry/d162384e-0291-4ae8-bce1-564dafd4d798) - [Investigator](https://www.keypedia.com/people/lesley-satterwhite/030978c6-daaa-42e9-bf63-f90a5647f0f0)